Octapharma Plasma Inc FDA Inspection Record

FEI 2077760 · Inspections, Form 483s, warning letters and import refusals

Octapharma Plasma Inc is an FDA-inspected facility (FEI 2077760) located in Van Nuys, CA, US. RegDataLab tracks 5 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Jan 16, 2025: No Action Indicated (NAI)
Inspections on record
5 (2 VAI, 3 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
23, latest Mar 13, 2008

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Jan 16, 2025No Action Indicated (NAI)No citations listed
Jun 9, 2017No Action Indicated (NAI)No citations listed
Aug 5, 2015No Action Indicated (NAI)No citations listed
Apr 12, 2013Voluntary Action Indicated (VAI)Determination of lot numbers and supplies (21 CFR 606.160(a)(2))
Clean & orderly (21 CFR 606.40)
Establish, maintain and follow manufacturing SOPs (21 CFR 606.100(b))
Sep 30, 2010Voluntary Action Indicated (VAI)Donor criteria (21 CFR 606.100(b)(1))
Donor notification (21 CFR 606.100(b)(21))
Supplemental results (21 CFR 630.40(a))
Notification (21 CFR 630.40(a))

Recalls

Showing the 10 most recent of 23 recalls. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Mar 13, 2008Class IIIB-2252-13Source Plasma
Blood product, in which donor donated without an acceptable arm check, was distributed.
Nov 2, 2004Class IIIB-0718-5Source Plasma
Blood Product, collected from a donor whose arm inspection was not documented, was distributed.
Sep 20, 2004Class IIIB-0555-5Source Plasma
Blood product, collected from a donor for which there was no documentation on the donor record of an arm inspection, was distributed.
Sep 14, 2004Class IIB-0577-5Source plasma
Blood products, collected from an unsuitable donor based on an unexplained weight loss, were distributed.
Aug 23, 2004Class IIIB-0571-5Source Plasma
Blood product, collected from a donor that did not answer the medical history questions, was distributed.
Aug 10, 2004Class IIIB-0572-5Source Plasma
Blood product, collected from a donor that did not answer the medical history questions, was distributed.
Jun 22, 2004Class IIIB-2323-5Source Plasma
Blood product, collected from a donor for whom there was no documentation on the donor record of an arm inspection, was distributed.
Apr 15, 2004Class IIIB-2326-5Source Plasma
Blood product, collected from a donor for whom there was no documentation on the donor record of an arm inspection, was distributed.
Jan 7, 2004Class IIIB-2322-5Source Plasma
Blood product, collected from a donor for whom there was no documentation on the donor record of an arm inspection, was distributed.
Dec 24, 2003Class IIIB-2271-5Source Plasma
Blood product, collected from a donor whose arm inspection was not documented, was distributed.

FDA record score

0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 22, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

4 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIApr 12, 201310 years or older, so it adds no points0
Inspection classified VAISep 30, 201010 years or older, so it adds no points0
Class II recall B-0577-5, this FEI as the recalling firmSep 14, 200410 years or older, so it adds no points0
Class II recall B-0759-3, this FEI as the recalling firmNov 25, 200210 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 22, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 22, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 22, 2026Newest record Nov 13, 2026Current
Warning letter textNov 22, 2026Newest record Nov 17, 2026Current
Recalls (Enforcement Report)Nov 22, 2026Newest record Nov 18, 2026Current
Form 483s and inspection documentsNov 18, 2026Newest record Nov 17, 2026Current
Import refusalsNov 22, 2026Newest record Nov 12, 2026Current

Reviewing Octapharma Plasma Inc as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Octapharma Plasma Inc yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Octapharma Plasma Inc
Location
Van Nuys, CA (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.